Register
WHO hails 'triumph' as Merck's Ebola vaccine gets European green light |
Clinical News
eMediNexus Coverage from: 
WHO hails 'triumph' as Merck's Ebola vaccine gets European green light

0 Read Comments                

The world’s first Ebola vaccine was recommended for approval by European drugs regulators on Friday in a move hailed by the World Health Organization (WHO) as a “triumph for public health” that would save many lives.

The vaccine, developed by U.S. drugmaker Merck & Co, is already being used under emergency guidelines to try to protect people against the spread of a deadly Ebola outbreak in Democratic Republic of Congo. It protects against the Zaire strain of the Ebola virus - the one that most commonly causes outbreaks… (Reuters, October 18, 2019)

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now